| |
| |
|
| Insider
Information: |
Baker Mark Robert |
| Relationship: |
CEO, Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
161,141 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$660,678 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
161,141 |
|
|
| Total
Value |
$660,678 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
CEO, Director |
2013-03-27 |
161,141 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
GNL COUNSELOfficer |
• – – |
2005-06-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
500 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-03-28 |
4 |
AB |
$10.00 |
$3,475 |
D/D |
343 |
40,312 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-07-25 |
4 |
AB |
$10.04 |
$3,473 |
D/D |
346 |
41,826 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-04-25 |
4 |
AB |
$9.92 |
$3,506 |
D/D |
348 |
40,660 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-01-25 |
4 |
AB |
$9.45 |
$3,470 |
D/D |
364 |
39,600 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-02-22 |
4 |
AB |
$9.40 |
$3,474 |
D/D |
369 |
39,969 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-06-27 |
4 |
AB |
$9.21 |
$3,477 |
D/D |
375 |
41,480 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-01-11 |
4 |
AB |
$8.86 |
$3,466 |
D/D |
391 |
39,236 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-05-23 |
4 |
AB |
$7.81 |
$3,475 |
D/D |
445 |
41,105 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2006-04-03 |
4 |
D |
$25.61 |
$11,627 |
D/D |
(454) |
2,402 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
officerTitle |
• – – |
2006-01-03 |
4 |
D |
$25.84 |
$12,326 |
D/D |
(477) |
2,316 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-04-27 |
4 |
AB |
$7.24 |
$3,468 |
D/D |
479 |
30,946 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-05-25 |
4 |
AB |
$7.13 |
$3,465 |
D/D |
486 |
31,432 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-06-22 |
4 |
AB |
$7.08 |
$3,469 |
D/D |
490 |
31,922 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2006-04-03 |
4 |
OE |
$21.77 |
$10,885 |
D/D |
500 |
2,856 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-01-03 |
4 |
D |
$26.66 |
$13,597 |
D/D |
(510) |
10,953 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-10-26 |
4 |
AB |
$6.50 |
$3,467 |
D/D |
532 |
38,211 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
officerTitle |
• – – |
2006-01-03 |
4 |
OE |
$20.86 |
$11,244 |
D/D |
539 |
2,793 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-09-28 |
4 |
AB |
$6.38 |
$3,463 |
D/D |
542 |
37,029 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-04-02 |
4 |
D |
$24.10 |
$13,496 |
D/D |
(560) |
11,065 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-07-27 |
4 |
AB |
$6.12 |
$3,472 |
D/D |
567 |
35,916 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2006-10-02 |
4 |
D |
$23.03 |
$13,150 |
D/D |
(571) |
10,841 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-01-03 |
4 |
OE |
$21.88 |
$12,493 |
D/D |
571 |
11,463 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-08-24 |
4 |
AB |
$6.08 |
$3,472 |
D/D |
571 |
36,487 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-04-02 |
4 |
OE |
$20.13 |
$12,501 |
D/D |
621 |
11,625 |
0 |
- |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
